146 related articles for article (PubMed ID: 23882055)
1. Is glucose control important for prevention of cardiovascular disease in diabetes?
Mannucci E; Dicembrini I; Lauria A; Pozzilli P
Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S259-63. PubMed ID: 23882055
[No Abstract] [Full Text] [Related]
2. Preventing cardiovascular disease in diabetes.
Harvey JN
Clin Med (Lond); 2004; 4(4):311-4. PubMed ID: 15372888
[No Abstract] [Full Text] [Related]
3. Emerging Targets for Cardiovascular Disease Prevention in Diabetes.
Stitziel NO; Kanter JE; Bornfeldt KE
Trends Mol Med; 2020 Aug; 26(8):744-757. PubMed ID: 32423639
[TBL] [Abstract][Full Text] [Related]
4. Obesity, Diabetes, and Cardiovascular Diseases: A Compendium.
Scherer PE; Hill JA
Circ Res; 2016 May; 118(11):1703-5. PubMed ID: 27230636
[No Abstract] [Full Text] [Related]
5. Higher cardiovascular risk for women throughout the glycaemic spectrum: only a question of sex?
Pedicino D; Galiuto L
Eur Heart J; 2023 Nov; 44(44):4620-4621. PubMed ID: 37769346
[No Abstract] [Full Text] [Related]
6. Cohort Profile: The DynaHEALTH consortium - a European consortium for a life-course bio-psychosocial model of healthy ageing of glucose homeostasis.
Sebert S; Lowry E; Aumüller N; Bermúdez MG; Bjerregaard LG; de Rooij SR; De Silva M; El Marroun H; Hummel N; Juola T; Mason G; Much D; Oliveros E; Poupakis S; Rautio N; Schwarzfischer P; Tzala E; Uhl O; van de Beek C; Vehmeijer F; Verdejo-Román J; Wasenius N; Webster C; Ala-Mursula L; Herzig KH; Keinänen-Kiukaanniemi S; Miettunen J; Baker JL; Campoy C; Conti G; Eriksson JG; Hummel S; Jaddoe V; Koletzko B; Lewin A; Rodriguez-Palermo M; Roseboom T; Rueda R; Evans J; Felix JF; Prokopenko I; Sørensen TIA; Järvelin MR
Int J Epidemiol; 2019 Aug; 48(4):1051-1051k. PubMed ID: 31321419
[No Abstract] [Full Text] [Related]
7. Prevention of Cardiovascular Disease in Type 1 Diabetes.
Maahs DM; Svensson J
N Engl J Med; 2024 Jun; 390(23):2226-2227. PubMed ID: 38899714
[No Abstract] [Full Text] [Related]
8. Prevention of Cardiovascular Disease in Type 1 Diabetes.
Wenstedt EFE; Vogt L
N Engl J Med; 2024 Jun; 390(23):2226. PubMed ID: 38899713
[No Abstract] [Full Text] [Related]
9. Cardiovascular Prevention in Obese Patients Without Diabetes: Risk-based Strategies Are Needed.
Ferreira JP; Neves JS; Saraiva F
J Card Fail; 2024 Feb; 30(2):418-420. PubMed ID: 38128642
[No Abstract] [Full Text] [Related]
10. Type 2 Diabetes Mellitus: Now in the Cardiologist's Wheelhouse.
Blaha MJ; Khorsandi M
J Am Coll Cardiol; 2023 Oct; 82(16):1595-1597. PubMed ID: 37821169
[No Abstract] [Full Text] [Related]
11. Prevention of Cardiovascular Disease in Type 1 Diabetes.
Manrique-Acevedo C; Hirsch IB; Eckel RH
N Engl J Med; 2024 Apr; 390(13):1207-1217. PubMed ID: 38598575
[No Abstract] [Full Text] [Related]
12. Cardiometabolic Health: Actionable Prevention Strategies and New Care Models.
Leonards O; Aguilar D
Tex Heart Inst J; 2024 Jan; 51(1):. PubMed ID: 38287668
[No Abstract] [Full Text] [Related]
13. Sleep measures and cardiovascular disease in type 2 diabetes mellitus.
Engin M
Clin Med (Lond); 2024 Jan; 24(1):100021. PubMed ID: 38290693
[No Abstract] [Full Text] [Related]
14. Response to: Letter to the editor: Sleep measures and cardiovascular disease in type 2 diabetes mellitus.
Magri CJ; Xuereb S; Xuereb RA; Xuereb RG; Fava S; Galea J
Clin Med (Lond); 2024 Jan; 24(1):100023. PubMed ID: 38331387
[No Abstract] [Full Text] [Related]
15. Machine Learning Method and Hyperspectral Imaging for Precise Determination of Glucose and Silicon Levels.
Wawerski A; Siemiątkowska B; Józwik M; Fajdek B; Partyka M
Sensors (Basel); 2024 Feb; 24(4):. PubMed ID: 38400464
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T
Carriero F; Rubino V; Leone S; Montanaro R; Brancaleone V; Ruggiero G; Terrazzano G
Cells; 2023 Dec; 12(24):. PubMed ID: 38132162
[TBL] [Abstract][Full Text] [Related]
17. Risk Stratification in People with Diabetes for Fasting During Ramadan: Consensus from Arabic Association for the Study of Diabetes and Metabolism.
Shaltout I; Abdelwahab AM; El Meligi A; Hammad H; Abdelghaffar S; Elbahry A; Taha N; Elsaid NH; Gad A; Hammouda L; Abdelmaboud S; Soliman AR
Curr Diabetes Rev; 2024; 20(7):e201023222409. PubMed ID: 37867270
[TBL] [Abstract][Full Text] [Related]
18. The effects of conjugated linoleic acid supplementation on glycemic control, adipokines, cytokines, malondialdehyde and liver function enzymes in patients at risk of cardiovascular disease: a GRADE-assessed systematic review and dose-response meta-analysis.
Ghodoosi N; Rasaei N; Goudarzi K; Hashemzadeh M; Dolatshahi S; Omran HS; Amirani N; Ashtary-Larky D; Shimi G; Asbaghi O
Nutr J; 2023 Oct; 22(1):47. PubMed ID: 37794481
[TBL] [Abstract][Full Text] [Related]
19. Atherogenic index of plasma and its cardiovascular risk factor correlates among patients with type 2 diabetes in Uganda.
Lumu W; Bahendeka S; Wesonga R; Kibirige D; Kasoma RM; Ssendikwanawa E
Afr Health Sci; 2023 Mar; 23(1):515-527. PubMed ID: 37545918
[TBL] [Abstract][Full Text] [Related]
20. Predicting 1-year mortality of patients with diabetes mellitus in Kazakhstan based on administrative health data using machine learning.
Alimbayev A; Zhakhina G; Gusmanov A; Sakko Y; Yerdessov S; Arupzhanov I; Kashkynbayev A; Zollanvari A; Gaipov A
Sci Rep; 2023 May; 13(1):8412. PubMed ID: 37225754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
